Cohen Global, Ltd.
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes (NCT06739707) | Cohen Global, Ltd. | 2025-01-02 |
| Subcutaneous Administration of MD-18 in Healthy Subjects (NCT06259903) | Cohen Global, Ltd. | 2024-05-07 |
Track Cohen Global, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.